Oncology Letters · 2022 · 15 citations · 39 references
MedicineCancer BiologyPharmacologyCancer PharmacologyMetastasisMolecular OncologyCancer Cell SignalingCancer ProgressionCancer Stem CellsMalignant NeoplasmsOvarian CancerCancer Stem-like CellsEpithelial-mesenchymal Transition In CancerEpithelial-mesenchymal Transition MarkersMesenchymal TransitionOvarian Cancer MetastasisOvarian Cancer TreatmentTumor Cell ProliferationTumor Growth Rate
Ovarian cancer has the worst prognosis among all types of gynecological malignancies and patients are often diagnosed at an advanced stage with distant metastasis. In the present study, it was found that emodin, a small molecular chemical drug derived from natural plants, has antitumor effects on ovarian cancer cells. Emodin induced cytotoxicity and inhibited proliferation in the ovarian cancer cell lines, SK-OV-3, A2780 and PA-1. In addition, emodin inhibited the migration and invasion abilities of the ovarian cancer cells by inhibiting epithelial-mesenchymal transition (EMT), which was evidenced by the downregulation of N-cadherin and vimentin, and the upregulation of E-cadherin protein expression levels. When a subcutaneous xenograft SK-OV-3 tumor mouse model was used, emodin notably reduced the tumor growth rate and inhibited tumor cell proliferation. Furthermore, mechanical analysis revealed that emodin markedly inhibited EMT and reduced the stemness of tumor cells, which was evidenced by the decrease in the protein expression of CD133 and Oct4. Pulmonary metastasis of the ovarian cancer cells was significantly suppressed in the tumor mouse model by the administration of emodin. In addition, flow cytometry analysis indicated that emodin significantly reduced the proportion of ovarian cancer stem-like cells in metastatic lung tissues. In conclusion, emodin, a potent inhibitor of EMT, could serve as a potential candidate for ovarian cancer therapy.
39
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Sendurai A. Mani, Wenjun Guo, Mai-Jing Liao et al. · Cell · 2008 · 8.7K citations · Full text
Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition
Anne‐Pierre Morel, Marjory Lièvre, Clémence Thomas et al. · PLoS ONE · 2008 · 1.6K citations · Full text
Medicine, Cancer Biology, Oncology +17
Clinical Evolution of Epithelial–Mesenchymal Transition in Human Carcinomas
Tony Navas, Robert J. Kinders, Scott M. Lawrence et al. · Cancer Research · 2019 · 97 citations · Full text
Medicine, Cell Biology, Oncology +17